These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37023475)

  • 21. Accelerated Wound Closure of Deep Partial Thickness Burns with Acellular Fish Skin Graft.
    Stone R; Saathoff EC; Larson DA; Wall JT; Wienandt NA; Magnusson S; Kjartansson H; Natesan S; Christy RJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes.
    McGloin H; Devane D; McIntosh CD; Winkley K; Gethin G
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012835. PubMed ID: 35653236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.
    Snyder RJ; Cardinal M; Dauphinée DM; Stavosky J
    Ostomy Wound Manage; 2010 Mar; 56(3):44-50. PubMed ID: 20368673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of chronic diabetic foot ulcers using platelet-rich plasma.
    Babaei V; Afradi H; Gohardani HZ; Nasseri F; Azarafza M; Teimourian S
    J Wound Care; 2017 Dec; 26(12):784-787. PubMed ID: 29244965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost Effectiveness of Fish Skin Grafts Versus Standard of Care on Wound Healing of Chronic Diabetic Foot Ulcers: A Retrospective Comparative Cohort Study.
    Winters C; Kirsner RS; Margolis DJ; Lantis JC
    Wounds; 2020 Oct; 32(10):283-290. PubMed ID: 33370245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
    Armstrong DG; Galiano RD; Orgill DP; Glat PM; Carter MJ; Di Domenico LA; Reyzelman AM; Zelen CM
    Int Wound J; 2022 May; 19(4):932-944. PubMed ID: 35080127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study.
    Snyder RJ; Kasper MA; Patel K; Carter MJ; Kushnir I; Kushnir A; Serena TE
    Wounds; 2018 Jul; 30(7):84-89. PubMed ID: 29718812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomised placebo-controlled trial assessing the efficacy of silver dressings to enhance healing of acute diabetes-related foot ulcers.
    Lafontaine N; Jolley J; Kyi M; King S; Iacobaccio L; Staunton E; Wilson B; Seymour C; Rogasch S; Wraight P
    Diabetologia; 2023 Apr; 66(4):768-776. PubMed ID: 36629877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
    Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fish Skin Grafts with Omega-3 for Treatment of Chronic Wounds: Exploring the Role of Omega-3 Fatty Acids in Wound Healing and A Review of Clinical Healing Outcomes.
    Seth N; Chopra D; Lev-Tov H
    Surg Technol Int; 2022 May; 40():38-46. PubMed ID: 35483381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
    Rastogi A; Kulkarni SA; Agarwal S; Akhtar M; Arsule S; Bhamre S; Bhosle D; Desai S; Deshmukh M; Giriraja KV; Jagannath J; Kashiva RY; Kesavan R; Khandelwal D; Kolte S; Kongara S; Darivemula AK; Madhusudan C; Pyare Saheb Qureshi MAH; Ramu M; Rathod G; Yalamanchi SR; Shakya S; Shetty P; Singh S; Deshpande SK; Viswanathan V; Unnikrishnan AG
    JAMA Netw Open; 2023 May; 6(5):e2311509. PubMed ID: 37184839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials.
    Galiano R; Snyder R; Mayer P; Rogers LC; Alvarez O;
    J Wound Care; 2019 Jun; 28(6):383-395. PubMed ID: 31166864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
    Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.
    Sledge I; Maislin D; Bernarducci D; Snyder R; Serena TE
    J Wound Care; 2020 Sep; 29(Sup9):S8-S12. PubMed ID: 32924804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical antimicrobial agents for treating foot ulcers in people with diabetes.
    Dumville JC; Lipsky BA; Hoey C; Cruciani M; Fiscon M; Xia J
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011038. PubMed ID: 28613416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
    Blume PA; Walters J; Payne W; Ayala J; Lantis J
    Diabetes Care; 2008 Apr; 31(4):631-6. PubMed ID: 18162494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
    Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
    Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.